Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:G01N33/48

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2020/233147INERT CARRIER ESCHERICHIA COLI AND POTENTIAL USE THEREOF
WO 26.11.2020
Int.Class C12N 1/20
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
20Bacteria; Culture media therefor
Appl.No PCT/CN2020/071625 Applicant YANGZHOU UNIVERSITY Inventor ZHU, Guoqiang
Disclosed are an inert carrier Escherichia coli and the use thereof, wherein the inert carrier Escherichia coli has been deposited in the China General Microbiological Culture Collection Center (CGMCC), with a deposit address of Beijing, China, a deposit number of CGMCC No. 17339, a deposit date of March 18, 2019, a classification name of Escherichia coli, and a strain code of SE1. The Escherichia coli does not cause any macroscopic agglutination reaction with various chicken sera of different genetic backgrounds, i.e., does not generate a non-specific agglutination reaction with different kinds of chicken sera, has the properties of being expressed and displayed on the surface a specific antigen protein, and is used as an inert carrier in an indirect agglutination test for detecting antigens or antibodies.
2.WO/2020/234287METHOD FOR PREPARING A PEPTIDE SAMPLE
WO 26.11.2020
Int.Class G01N 33/68
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
Appl.No PCT/EP2020/063944 Applicant CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER Inventor LEHMANN, Sylvain
The present application relates to a method for preparing a peptide sample from a biological sample, and to a method for detecting or quantifying proteins comprising said method for preparing a sample. The invention also relates to the use of these methods for the detection or monitoring of a condition or a disease.
3.WO/2020/234617METHODS AND SYSTEMS FOR MANUFACTURING A PRODUCTION ASSAY REACTOR
WO 26.11.2020
Int.Class G16C 20/10
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
20Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
10Analysis or design of chemical reactions, syntheses or processes
Appl.No PCT/IB2019/000561 Applicant BIOMERIEUX Inventor DRAZEK, Laurent
The invention provides for methods and systems involving the measurement of values of one or several characterizing parameters representative of the kinetics of an assay chemical reaction, including - providing a calibration tool (26) comprising a reaction chamber (28); - for a given set of defining features, performing a series of calibration experiments under different sets of calibration values of at least one operating parameter, - providing a digital calibration model representative of the kinetics of the assay chemical reaction in the calibration tool, where the assay digital calibration model comprises one or several characterizing parameters, the values of which have a dependency on the given set of defining features used for the calibration experiments; -fitting, by computation, the values of the characterizing parameters for the given set of defining features, based on the series of calibration experiment results, wherein the reaction chamber (28) is a stirred-tank reactor.
4.WO/2020/234647METHODS OF DIAGNOSING AND TREATING CERVICAL CANCER
WO 26.11.2020
Int.Class G01N 33/574
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
Appl.No PCT/IB2020/000395 Applicant ATSO CORPORATE AFFAIRS Inventor ROJAS, Alberto, Checa
The present invention is related to diagnostic tests or rapid detections of different types of cancer, especially cervical cancer and precancerous lesions. Especially, the invention relates to specific and useful protein biomarkers for the detection of said diseases, and to the methods for determination and detection of said biomarkers.
5.WO/2020/235567FLUORESCENT PROBE FOR USE IN DETECTION OF BRAIN TUMOR
WO 26.11.2020
Int.Class C07K 5/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
06Dipeptides
Appl.No PCT/JP2020/019814 Applicant THE UNIVERSITY OF TOKYO Inventor KITAGAWA Yosuke
[Problem] To provide a novel fluorescent probe which can be used in a spray mode, has excellent specificity to sensitivity, also has immediacy, and enables the detection of brain tumor. [Solution] A fluorescent probe for use in the detection of brain tumor, which comprises a compound represented by formula (I) or a salt thereof: (in the formula, P1 represents an arginine residue, a histidine residue or a tyrosine residue, and P2 represents a proline residue or a glycine residue, wherein P1 is liked to an adjacent N atom to form an amide bond, and P2 is linked to P1 to form an amide bond; R1 represents 1 to 4 same or different substituents independently selected from the group consisting of a hydrogen atom and an alkyl group, a carboxyl group, an ester group, an alkoxy group, an amide group and an azide group each of which may be substituted; R2, R3, R4, R5, R6 and R7 independently represent a hydrogen atom, a hydroxyl group, an alkyl group which may be substituted, or a halogen atom; R8 and R9 independently represent a hydrogen atom or an alkyl group; X represents O, Si(Ra)(Rb), Ge(Ra)(Rb), Sn(Ra)(Rb), C(Ra)(Rb) or P(=O)(Ra); Ra and Rb independently represent a hydrogen atom, an alkyl group or an aryl group; and Y represents a C1-C3 alkylene group).
6.WO/2020/235607METHOD FOR DETECTING TARGET MOLECULE
WO 26.11.2020
Int.Class G01N 37/00
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
37Details not covered by any other group of this subclass
Appl.No PCT/JP2020/019992 Applicant TOPPAN PRINTING CO., LTD. Inventor HIRASE Takumi
This method for detecting a surface target molecule and an internal target molecule of a structure comprises steps for: bringing a liquid having a structure dispersed therein into contact with a well array having a plurality of wells so as to introduce the structure into the wells; bringing an encapsulation liquid into contact with the well array so as to cause the structure to be encapsulated within each of the wells; extracting content of the structure within each of the wells; detecting at least one type of surface target molecule present on the surface of the structure within each of the wells; and detecting at least one type of internal target molecule present inside the structure within each of the wells.
7.WO/2020/235697IMPROVED METHOD FOR MANUFACTURING MICRONEEDLE-BASED DIAGNOSTIC SKIN PATCH COATED WITH APTAMER, AND PATCH
WO 26.11.2020
Int.Class G01N 33/543
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
543with an insoluble carrier for immobilising immunochemicals
Appl.No PCT/KR2019/005921 Applicant NEXMOS CO., LTD. Inventor SON, In Sik
The present invention relates to a method for manufacturing a microneedle-based diagnostic skin patch coated with an aptamer, the method comprising a step for treating the surface of a microneedle with a base to modify the surface with a carboxyl group, and binding an aptamer having an amine group. A patch according to the present invention is advantageous in that a large number of aptamers, which are much smaller in size than antibody materials, can be attached to a relatively large number of microneedle tip surfaces. In addition, since aptamers for various kinds of biomarkers can be attached at the same time, various kinds of materials can be detected simultaneously (multiplexing), and thus even a microneedle tip-based skin patch can be used as a protein chip using aptamers.
8.WO/2020/235757METHOD FOR SCREENING CANDIDATE DRUG FOR TREATING DEGENERATIVE BRAIN DISEASES
WO 26.11.2020
Int.Class G01N 33/68
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
Appl.No PCT/KR2019/014071 Applicant THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) Inventor KIM, Eunhee
In the present invention, it has been confirmed that FAF1 protein, which is reported to induce neuronal death, is secreted through exocytosis while being contained in exosomes, not through general protein transport pathways, thereby inducing apoptosis of other cells, and thus, through a process for selecting a test substance capable of suppressing the extracellular secretion of FAF1 protein, it is possible to screen for a therapeutic agent for degenerative brain diseases of which the major cause is neuronal death.
9.WO/2020/234026ENDOMENTRIAL RECEPTIVITY DETERMINATION
WO 26.11.2020
Int.Class G01N 33/68
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
Appl.No PCT/EP2020/063066 Applicant TERVISETEHNOLOOGIATE ARENDUSKESKUS AS Inventor SALUMETS, Andres
Endometrial receptivity status is determined by measuring, in an uterine fluid sample taken from a woman, the amounts of at least three proteins selected among NNMT, LCN2, PGR, SLC26A2, SLC34A2, TCN1, ENPP3, GRN, STC1, DPP4, MPO, CD55, ELANE, MSLN, CTSB, RNASET2, CRISP3, MVP, MMP26, AOC1 and SDCBP2. The EM receptivity status of the woman is determined based on a comparison of the measured amounts of the at least three proteins with respective control amounts.
10.WO/2020/235566METHOD FOR WASHING EXTRACELLULAR VESICLE
WO 26.11.2020
Int.Class C12N 5/07
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07Animal cells or tissues
Appl.No PCT/JP2020/019808 Applicant H.U. GROUP RESEARCH INSTITUTE G.K. Inventor GU, Ran
The present invention provides a technique for reducing the contamination with contaminants in a system in which an extracellular vesicle is manipulated. More specifically, the present invention provides: a method for washing an extracellular vesicle, comprising washing the extracellular vesicle with a nonionic surfactant that is a linear compound containing a structure represented by the formula: -O-(-CH2-CH2-O-)x-H [wherein x represents a value defined in the description]; and others.